Home / Research projects / Role of oral microbiota as a potential predictor of response to immunotherapy treatments in non-small cell lung cancer
Share
Role of oral microbiota as a potential predictor of response to immunotherapy treatments in non-small cell lung cancer
Project objectives
Identification of a specific composition of the oral microbiota capable of predicting the benefit of immunotherapy treatments in patients with advanced non-small cell lung cancer
Analysis of specific metabolites produced by the identified bacterial species to evaluate their ability to modulate the immune system and response to immunotherapy
Evaluation of a possible modulation of the composition of the oral microbiota through specific dietary interventions and/or through the use of antibiotics to make the patient responsive to treatment
Start and end date
November 2021 – ongoing (July 2024 approximate end date)
Project Manager
Francesco Pantano (PI)
Coordinating institution of the project
Università Campus Bio-Medico di Roma
Other Institutions involved
Analysis Laboratory, Campus Bio-Medico University Hospital Foundation
L'Università Campus Bio-Medico di Roma promotes integrated teaching and research structures, pursuing the good of the person as the main aim of its activities.